// App-Quantinova.ai

O26 : Effects of baseline prednisone dose on remission and disease flare in patients with giant cell arteritis treated with tocilizumab in the GiACTA trial

Researchers

Presenter

  • John H Stone

Principal Investigators

  • Katie Tuckwell

  • Sophie Dimonaco

  • Micki Klearman

  • Martin Aringer

  • Daniel Blockmans

  • Elisabeth Brouwer

  • Maria C Cid

  • Bhaskar Dasgupta

  • Juergen Rech

  • Carlo Salvarani

  • Hendrik Schulze-Koops

  • Georg Schett

  • Robert F Spiera

  • Sebastian H Unizony

  • Neil Collinson

Medical Centers

  • Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA

  • Genentech, Inc., South San Francisico, CA

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • Rheumatology, Medicine III, University Medical Center and Faculty of Medicine TU Dresden, Dresden, GERMANY

  • Department of Clinical and Experimental Medicine, University Hospital Gasthuisberg, Leuven, BELGIUM

  • University Medical Center, University of Gröningen, Gröningen, NETHERLANDS

  • Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, SPAIN

  • Southend University Hospital NHS Trut, Westcliff on Sea, United Kingdom

  • n/a, Universitätsklinikum Erlangen, Erlangen, GERMANY

  • Dipartimento di Medicina Interna e Specialità Mediche, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, ITALY

  • Division of Rheumatology, Ludwig-Maximilians-University of Munich, Munich, GERMANY

  • Friedrich-Alexander-Universität Erlangen, Nürnberg und Universitätsklinikum Erlangen, Erlangen, Germany

  • Hospital for Special Surgery, New York, NY.

Locations

  • United States

  • United Kingdom

  • Germany

  • Belgium

  • Netherlands

  • Spain

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Giant cell arteritis

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

Drug/Treatment

  • Tocilizumab

  • Prednisone

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • NCT01791153

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved